Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease

Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention increases the risk of bleeding. We studied the safety and clinical outcomes of switching from DAPT to aspirin monotherapy at 3 months after ZES implantation. We retrospectively evaluated 168 consecutive patients with coronary...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wada, Tadashi, Nakahama, Makoto, Toda, Hironobu, Watanabe, Atsuyuki, Hashimoto, Katsushi, Terasaka, Ritsuko, Nakamura, Kazufumi, Yamada, Nobuyuki, Ito, Hiroshi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2013
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3649238/
https://ncbi.nlm.nih.gov/pubmed/23762606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/518968
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak